Attend the Medicinal Chemistry Summit: Europe (29–30 October 2018)
Announcing the 2nd Medicinal Chemistry Summit: Europe, part of Global Engage’s Drug Discovery Series, taking place in London.
Global Engage is pleased to announce, as part of their Drug Discovery Series of events, the 2nd Medicinal Chemistry Summit: Europe – a key, senior level R&D event that was hugely successful last year, confirmed to be held on 29–30 October 2018 in London, UK. This conference will be co-located with the 2nd Global Pharma R&D Informatics and AI Congress
Designed to attract experts working in all areas of medicinal chemistry, the Summit has three tracks focusing on key topics such as hit-to-lead optimization, protein degradation, DNA encoded libraries, structure-based drug design, small molecule targeting of RNAs, immuno-oncology research and the use of artificial intelligence in the drug discovery process. The Summit will provide a forum to network, learn, and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.
This extensive event boasts over 30 presentations as well as in depth roundtable discussions, an expert led panel discussion and over 6 hours of dedicated networking time, connecting you with industry leaders, academics and senior level executives.
Expert speakers include:
- Ian Churcher – Senior Vice President of Research, BenevolentAI (London, UK)
- Andrew Phillips – President & CEO, C4 Therapeutics (MA, USA)
- Werngard Czechtizky – Head of Medicinal Chemistry, Respiratory, Inflammation & Autoimmunity, AstraZeneca (Gothenburg, Sweden)
- Ingo Hartung - Vice President of Medicinal Chemistry, R&D Pharmaceuticals, Bayer AG (Leverkusen, Germany)